1-4 of 4
Ewa Lesko, MSci
Close
Sort by
Journal Articles

Comparison of Different Strategies of MSC Isolation Revels Advantage To Expand MSC Directly from Purified CD105 + and CD271 + Cells.

Danuta Jarocha, MSci, Ewa Lesko, MSci, Mariusz Z. Ratajczak, MD, PhD, Marcin Majka, PhD
Journal: Blood
Blood (2006) 108 (11): 2566.
https://doi.org/10.1182/blood.V108.11.2566.2566
Published: 2006
Journal Articles

Different Sensitivity of Normal and Malignant Cells to HSP90 Inhibitors.

Ewa Lesko, MSci, Anna Zebzda, MSci, Danuta Jarocha, Msci, Marcin Majka, PhD
Journal: Blood
Blood (2006) 108 (11): 4377.
https://doi.org/10.1182/blood.V108.11.4377.4377
Published: 2006
Journal Articles

Comparison of Myeloma Cells Killing Efficiency by Geldanamycin and Its Analogs.

Anna Zebzda, MSci, Artur Jurczyszyn, MD,PhD, Wojciech Czogala, MD, Ewa Lesko, MSci, Jolanta Gozdzik, MD,PhD, Aleksander B. Skotnicki, MD,PhD, Marcin Majka, PhD
Journal: Blood
Blood (2006) 108 (11): 5027.
https://doi.org/10.1182/blood.V108.11.5027.5027
Published: 2006
Journal Articles

C-met Receptor as a Potential Target for the Treatment of Patients with Multiple Myeloma.

Marcin Majka, PhD, Artur Jurczyszyn, MD, PhD, Anna Zebzda, MSci, Wojciech Czogala, MD, Ewa Lesko, MSci, Zbigniew Rudzki, MD, PhD, Jolanta Gozdzik, MD, PhD, Teresa Wolska-Smolen, MD, PhD, Aleksander B. Skotnicki, MD, PhD, Mariusz Z. Ratajczak, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3395.
https://doi.org/10.1182/blood.V106.11.3395.3395
Published: 2005